CTOR
Citius Oncology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.81
-0.10 ▼ -10.73%
🌙 3월 13일 7:11 PM ET (한국 3/14 08:11)
$0.79
-0.02 ▼ -2.38%
| Index | - | P/E | - | EPS (ttm) | -0.31 | Insider Own | 81.22% | Shs Outstand | 0.08B | Perf Week | -20.35% |
| Market Cap | 0.07B | Forward P/E | 2.08 | EPS next Y | 343.75% | Insider Trans | - | Shs Float | 0.02B | Perf Month | -28.11% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | -0.01 | Inst Own | 7.77% | Short Float | 5.94% | Perf Quarter | -28.11% |
| Income | -0.02B | P/S | 18.2 | EPS this Y | 52.94% | Inst Trans | 0.69% | Short Ratio | 2.6 | Perf Half Y | -57.02% |
| Sales | 0.00B | P/B | 1.18 | EPS next 5Y | - | ROA | -23.58% | Short Interest | 0.99M | Perf YTD | -18.76% |
| Book/sh | 0.69 | P/C | 9.82 | EPS past 3/5Y | - -309.67% | ROE | -47.41% | 52W High | -86.88% ($6.19) | Perf Year | 9.78% |
| Cash/sh | 0.08 | P/FCF | - | Sales past 3/5Y | - | ROIC | -37.99% | 52W Low | 47.55% ($0.55) | Perf 3Y | -92.14% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -61.87% | Gross Margin | 79.99% | Volatility(W/M) | 9.24% 6.65% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 17.31 | Sales Y/Y TTM | - | Oper. Margin | -567.43% | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.32 | EPS Q/Q | 32.01% | Profit Margin | -599.28% | RSI (14) | 23.08 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.83 | Sales Q/Q | - | SMA20 | -24.43% ($1.07) | Beta | 3.13 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2000000 | SMA50 | -25.77% ($1.09) | Rel Volume | 1.21 | Prev Close | $0.91 |
| Employees | - | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | - -9.81% | SMA200 | -50.13% ($1.62) | Avg Volume(3M) | 0.38M | Price | $0.81 |
| IPO | 2022/12/8 | Option/Short | No/Yes | Trades | 998 | Volume | 458,929 | Change | -10.73% |
뉴스 로딩 중...